Heterozygous midnolin knockout attenuates severity of nonalcoholic fatty liver disease in mice fed a Western-style diet high in fat, cholesterol, and fructose.

Autor: Soo-Mi Kweon, Irimia-Dominguez, Jose, Gayeoun Kim, Fueger, Patrick T., Kinji Asahina, Lai, Keith K., Allende, Daniela S., Lai, Quincy R., Chih-Hong Lou, Tsark, Walter M., Ju Dong Yang, Ng, Dominic S., Ju-Seog Lee, Tso, Patrick, Wendong Huang, Lai, Keane K. Y.
Předmět:
Zdroj: American Journal of Physiology: Gastrointestinal & Liver Physiology; Aug2023, Vol. 325 Issue 2, pG147-G157, 11p
Abstrakt: Although midnolin has been studied for over 20 years, its biological roles in vivo remain largely unknown, especially due to the lack of a functional animal model. Indeed, given our recent discovery that the knockdown of midnolin suppresses liver cancer cell tumorigenicity and that this antitumorigenic effect is associated with modulation of lipid metabolism, we hypothesized that knockout of midnolin in vivo could potentially protect from nonalcoholic fatty liver disease (NAFLD) which has become the most common cause of chronic liver disease in the Western world. Accordingly, in the present study, we have developed and now report on the first functional global midnolin knockout mouse model. Although the overwhelming majority of global homozygous midnolin knockout mice demonstrated embryonic lethality, heterozygous knockout mice were observed to be similar to wild-type mice in their viability and were used to determine the effect of reduced midnolin expression on NAFLD. We found that global heterozygous midnolin knockout attenuated the severity of NAFLD in mice fed a Western-style diet, high in fat, cholesterol, and fructose, and this attenuation in disease was associated with significantly reduced levels of large lipid droplets, hepatic free cholesterol, and serum LDL, with significantly differential gene expression involved in cholesterol/lipid metabolism. Collectively, our results support a role for midnolin in regulating cholesterol/lipid metabolism in the liver. Thus, midnolin may represent a novel therapeutic target for NAFLD. Finally, our observation that midnolin was essential for survival underscores the broad importance of this gene beyond its role in liver biology. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index